Derma Sciences, Inc, Princeton, New Jersey, a tissue regeneration company focused on advanced wound and burn care, has signed a definitive agreement to acquire BioD, LLC, Memphis, Tennessee. BioD is a privately held company that develops and commercializes novel proprietary regenerative medicine products derived from placental/birth tissues for use in a broad range of clinical applications. Derma Sciences had licensed 2 of BioD's products in 2014, Amnioexcel and Amniomatrix. Through this acquisition, Derma Sciences gains 4 BioD product families: BioDFactor Viable Tissue Matrix, BioDRestore Elemental Tissue Matrix, BioDFence Resorbable Adhesion Barrier, and BioDOptix Amniotic Extracellular Matrix.

[black up pointing small triangle]Information: http://www.dermasciences.com

Imbed Biosciences Inc, Madison, Wisconsin, was awarded the 2016 Wound Care Innovation Award for its microfilm wound dressing technology at the annual meeting of the European Wound Management Association conference in Bremen, Germany. The microfilm wound dressing technology platform is a transparent, thin, synthetic hydrogel film with a coating of ionic and metallic silver. When placed on a moist wound, the microfilm dressing absorbs wound moisture and forms a conforming gel sheet that can provide an antimicrobial barrier to infections for several days, according to the manufacturer. The product is currently under review for regulatory clearance for human use.

[black up pointing small triangle]Information: http://imbedbio.com